"Targeted therapy" trang 1 - tải miễn phí từ tailieunhanh
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
8    1    1
Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy

Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy
10    6    1
Ebook Cancer signaling: From molecular biology to targeted therapy

Ebook Cancer signaling: From molecular biology to targeted therapy
357    2    1
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy
12    54    1
Personalized medicine for effective treatment of nonsmall-cell lung cancer with targeted therapiesa

Personalized medicine for effective treatment of nonsmall-cell lung cancer with targeted therapiesa
15    57    1
Interleukin-6 mediates resistance to PI3Kpathway–targeted therapy in lymphoma

Interleukin-6 mediates resistance to PI3Kpathway–targeted therapy in lymphoma
11    81    0
Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study

Everolimus in metastatic renal cell carcinoma after failure of initial anti–VEGF therapy: Final results of a noninterventional study
10    44    1
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma

Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
8    45    1
In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy

In-silico discovery of cancer-specific peptide-HLA complexes for targeted therapy
14    35    1
Adverse reactions of targeted therapy in cancer patients: A retrospective study of hospital medical data in China

Adverse reactions of targeted therapy in cancer patients: A retrospective study of hospital medical data in China
13    46    1
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy
21    15    1
Delayed pharyngocutaneous fistula caused by molecular targeted therapy: A case report

Delayed pharyngocutaneous fistula caused by molecular targeted therapy: A case report
5    1    1
Chemotherapy and targeted therapy for advanced biliary tract cancers: An umbrella review

Chemotherapy and targeted therapy for advanced biliary tract cancers: An umbrella review
26    4    1
Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: A systematic review and meta-analysis of prognostic factors

Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: A systematic review and meta-analysis of prognostic factors
17    2    1
Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy

Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy
15    1    1
SPARKLE: A new spark in treating oligorecurrent prostate cancer: Adding systemic treatment to stereotactic body radiotherapy or metastasectomy: Key to long-lasting event-free survival?

SPARKLE: A new spark in treating oligorecurrent prostate cancer: Adding systemic treatment to stereotactic body radiotherapy or metastasectomy: Key to long-lasting event-free survival?
10    11    1
MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: A patient-based multi-parameter study

MRI in predicting the response of gastrointestinal stromal tumor to targeted therapy: A patient-based multi-parameter study
8    55    1
Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
9    35    1
The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy

The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy
13    27    1
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review

Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: A systematic review
15    56    1